|Conference Calls of Interest to Small-Cap BioMed Investors|
|By Jude Santos, BioMedReports|
|Tuesday, 22 September 2009 05:48|
There are two companies which have received coverage for their biomedical technologies that have upcoming conference calls which may be of interest to small-sap biotech investors.
The first call will feature Imaging3, Inc. (OTC.BB:IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time.
The call will feature company CEO, Mr. Dean JaneThat conference call will take place on Wednesday, September 23, 2009
at 3:00 pm ET, 2:00 pm CT, 1:00 pm MT, 12:00pm PDT, the company's CEO, Mr. Dean Janes, will be hosting a conference call to provide an update on the company's plans as well as an update on the FDA approval progress.
Dail-In Number: (866) 212-0875 Conference ID# 172951
You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation. A recording of the conference call will also be available on the company's website following the conference.
The second of these calls is going to be hosted by Dawson James Securities's Director of Research, Robert Wasserman who will speak at length about Oculus Innovative Sciences' (NASDAQ:OCLS) product Microcyn®- a novel non-antibiotic approach to the treatment of wound infections.
The call will feature two prominent medical experts:
Cheryl Bongiovanni, Ph.D. RVT, FASA
Adam Landsman, DPM, Ph.D.